Remco M.P. Brandt

Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability

Sjoerd H. van der Burg, Marjan J.W. Visseren, Remco M.P. Brandt et al. · The Journal of Immunology · 1996 · 392 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.

Maaike E. Ressing, Alessandro Sette, Remco M.P. Brandt et al. · The Journal of Immunology · 1995 · 386 citations

Life Sciences, Immunology, Oncology +17

Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins.

W. Martin Kast, Remco M.P. Brandt, John Sidney et al. · The Journal of Immunology · 1994 · 345 citations

Life Sciences, Immunology, Oncology +17

Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I–II trial

Willemien J. van Driel, Maaike E. Ressing, Gemma G. Kenter et al. · European Journal of Cancer · 1999 · 230 citations

Medicine, Immunology, Oncology +15

Detection of T Helper Responses, But Not of Human Papillomavirus-Specific Cytotoxic T Lymphocyte Responses, After Peptide Vaccination of Patients With Cervical Carcinoma

Maaike E. Ressing, Willemien J. van Driel, Remco M.P. Brandt et al. · Journal of Immunotherapy · 2000 · 172 citations

Medicine, Immunology, Oncology +17